The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous (IV) Solution Market Research Report 2024
Synopsis
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The global Intravenous (IV) Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Solution.
Report Scope
The Intravenous (IV) Solution market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous (IV) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous (IV) Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Segment by Type
Total Parenteral Solution
Peripheral Parenteral Solution
Segment by Application
Hospitals & Clinics
Ambulatory
Homecare
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous (IV) Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous (IV) Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The global Intravenous (IV) Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Solution.
Report Scope
The Intravenous (IV) Solution market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous (IV) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous (IV) Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Segment by Type
Total Parenteral Solution
Peripheral Parenteral Solution
Segment by Application
Hospitals & Clinics
Ambulatory
Homecare
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous (IV) Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous (IV) Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravenous (IV) Solution Market Overview
1.1 Product Overview and Scope of Intravenous (IV) Solution
1.2 Intravenous (IV) Solution Segment by Type
1.2.1 Global Intravenous (IV) Solution Market Value Comparison by Type (2024-2030)
1.2.2 Total Parenteral Solution
1.2.3 Peripheral Parenteral Solution
1.3 Intravenous (IV) Solution Segment by Application
1.3.1 Global Intravenous (IV) Solution Market Value by Application: (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory
1.3.4 Homecare
1.4 Global Intravenous (IV) Solution Market Size Estimates and Forecasts
1.4.1 Global Intravenous (IV) Solution Revenue 2019-2030
1.4.2 Global Intravenous (IV) Solution Sales 2019-2030
1.4.3 Global Intravenous (IV) Solution Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous (IV) Solution Market Competition by Manufacturers
2.1 Global Intravenous (IV) Solution Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous (IV) Solution Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous (IV) Solution Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous (IV) Solution Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous (IV) Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous (IV) Solution, Product Type & Application
2.7 Intravenous (IV) Solution Market Competitive Situation and Trends
2.7.1 Intravenous (IV) Solution Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous (IV) Solution Players Market Share by Revenue
2.7.3 Global Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous (IV) Solution Retrospective Market Scenario by Region
3.1 Global Intravenous (IV) Solution Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous (IV) Solution Global Intravenous (IV) Solution Sales by Region: 2019-2030
3.2.1 Global Intravenous (IV) Solution Sales by Region: 2019-2024
3.2.2 Global Intravenous (IV) Solution Sales by Region: 2025-2030
3.3 Global Intravenous (IV) Solution Global Intravenous (IV) Solution Revenue by Region: 2019-2030
3.3.1 Global Intravenous (IV) Solution Revenue by Region: 2019-2024
3.3.2 Global Intravenous (IV) Solution Revenue by Region: 2025-2030
3.4 North America Intravenous (IV) Solution Market Facts & Figures by Country
3.4.1 North America Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous (IV) Solution Sales by Country (2019-2030)
3.4.3 North America Intravenous (IV) Solution Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous (IV) Solution Market Facts & Figures by Country
3.5.1 Europe Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous (IV) Solution Sales by Country (2019-2030)
3.5.3 Europe Intravenous (IV) Solution Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous (IV) Solution Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous (IV) Solution Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous (IV) Solution Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous (IV) Solution Market Facts & Figures by Country
3.7.1 Latin America Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous (IV) Solution Sales by Country (2019-2030)
3.7.3 Latin America Intravenous (IV) Solution Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous (IV) Solution Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous (IV) Solution Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous (IV) Solution Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous (IV) Solution Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous (IV) Solution Sales by Type (2019-2030)
4.1.1 Global Intravenous (IV) Solution Sales by Type (2019-2024)
4.1.2 Global Intravenous (IV) Solution Sales by Type (2025-2030)
4.1.3 Global Intravenous (IV) Solution Sales Market Share by Type (2019-2030)
4.2 Global Intravenous (IV) Solution Revenue by Type (2019-2030)
4.2.1 Global Intravenous (IV) Solution Revenue by Type (2019-2024)
4.2.2 Global Intravenous (IV) Solution Revenue by Type (2025-2030)
4.2.3 Global Intravenous (IV) Solution Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous (IV) Solution Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous (IV) Solution Sales by Application (2019-2030)
5.1.1 Global Intravenous (IV) Solution Sales by Application (2019-2024)
5.1.2 Global Intravenous (IV) Solution Sales by Application (2025-2030)
5.1.3 Global Intravenous (IV) Solution Sales Market Share by Application (2019-2030)
5.2 Global Intravenous (IV) Solution Revenue by Application (2019-2030)
5.2.1 Global Intravenous (IV) Solution Revenue by Application (2019-2024)
5.2.2 Global Intravenous (IV) Solution Revenue by Application (2025-2030)
5.2.3 Global Intravenous (IV) Solution Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous (IV) Solution Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ICU Medical
6.1.1 ICU Medical Corporation Information
6.1.2 ICU Medical Description and Business Overview
6.1.3 ICU Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ICU Medical Intravenous (IV) Solution Product Portfolio
6.1.5 ICU Medical Recent Developments/Updates
6.2 B. Braun Melsungen
6.2.1 B. Braun Melsungen Corporation Information
6.2.2 B. Braun Melsungen Description and Business Overview
6.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B. Braun Melsungen Intravenous (IV) Solution Product Portfolio
6.2.5 B. Braun Melsungen Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Intravenous (IV) Solution Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Intravenous (IV) Solution Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Amanta Healthcare
6.5.1 Amanta Healthcare Corporation Information
6.5.2 Amanta Healthcare Description and Business Overview
6.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amanta Healthcare Intravenous (IV) Solution Product Portfolio
6.5.5 Amanta Healthcare Recent Developments/Updates
6.6 Terumo Medical
6.6.1 Terumo Medical Corporation Information
6.6.2 Terumo Medical Description and Business Overview
6.6.3 Terumo Medical Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Medical Intravenous (IV) Solution Product Portfolio
6.6.5 Terumo Medical Recent Developments/Updates
6.7 Grifols
6.6.1 Grifols Corporation Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Intravenous (IV) Solution Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Intravenous (IV) Solution Product Portfolio
6.7.5 Grifols Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous (IV) Solution Industry Chain Analysis
7.2 Intravenous (IV) Solution Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous (IV) Solution Production Mode & Process
7.4 Intravenous (IV) Solution Sales and Marketing
7.4.1 Intravenous (IV) Solution Sales Channels
7.4.2 Intravenous (IV) Solution Distributors
7.5 Intravenous (IV) Solution Customers
8 Intravenous (IV) Solution Market Dynamics
8.1 Intravenous (IV) Solution Industry Trends
8.2 Intravenous (IV) Solution Market Drivers
8.3 Intravenous (IV) Solution Market Challenges
8.4 Intravenous (IV) Solution Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
